Aging of the immune system: Mechanisms and therapeutic targets

Annals of the American Thoracic Society

Volumn 13, Issue , 2016, Pages S422-S428

  Weyand, Cornelia M ^a   Goronzy, Jörg J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA damage; Glycolysis; Immune aging; Inflammation; T cells

Indexed keywords

DNA; ATM PROTEIN;

CELL METABOLISM; CONFERENCE PAPER; DNA DAMAGE; HUMAN; IMMUNOSENESCENCE; NUCLEAR REPROGRAMMING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; AGING; CELL AGING; CELL SURVIVAL; DNA REPAIR; GENETICS; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION;

AGING; ARTHRITIS, RHEUMATOID; ATAXIA TELANGIECTASIA MUTATED PROTEINS; CELL SURVIVAL; CELLULAR SENESCENCE; DNA DAMAGE; DNA REPAIR; HUMANS; IMMUNE SYSTEM; IMMUNOSENESCENCE; INFLAMMATION; T-LYMPHOCYTES;

EID: 85008352617     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201602-095AW     Document Type: Conference Paper

References (59)

1. Bansilal S, Castellano JM, Fuster V. Global burden of CVD: focus on secondary prevention of cardiovascular disease. Int J Cardiol 2015; 201:S1-S7.
2. Hurme M, Korkki S, Lehtimäki T, Karhunen PJ, Jylhä M, Hervonen A, Pertovaara M. Autoimmunity and longevity: presence of antinuclear antibodies is not associated with the rate of inflammation or mortality in nonagenarians. Mech Ageing Dev 2007;128:407-408.
3. Kooman JP, Shiels PG, Stenvinkel P. Premature aging in chronic kidney disease and chronic obstructive pulmonary disease: similarities and differences. Curr Opin Clin Nutr Metab Care 2015;18: 528-534.
4. Murray MA, Chotirmall SH. The impact of immunosenescence on pulmonary disease. Mediators Inflamm 2015;2015:692546.
5. Johnstone J, Parsons R, Botelho F, Millar J, McNeil S, Fulop T, McElhaney J, Andrew MK, Walter SD, Devereaux PJ, et al. Immune biomarkers predictive of respiratory viral infection in elderly nursing home residents. PLoS One 2014;9:e108481.
6. Goronzy JJ, Fang F, Cavanagh MM, Qi Q, Weyand CM. Naive T cell maintenance and function in human aging. J Immunol 2015;194: 4073-4080.
7. Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol 2013;14:428-436.
8. Goronzy JJ, Weyand CM. Immune aging and autoimmunity. Cell Mol Life Sci 2012;69:1615-1623.
9. Goronzy JJ, Shao L, Weyand CM. Immune aging and rheumatoid arthritis. Rheum Dis Clin North Am 2010;36:297-310.
10. Goronzy JJ, Li G, Yang Z, Weyand CM. The Janus head of T cell aging-autoimmunity and immunodeficiency. Front Immunol 2013;4:131.
11. Weyand CM, Yang Z, Goronzy JJ. T-cell aging in rheumatoid arthritis. Curr Opin Rheumatol 2014;26:93-100.
12. Schmidt D, Goronzy JJ, Weyand CM. CD41 CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027-2037.
13. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD41, CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001;44:13-20.
14. Broux B, Markovic-Plese S, Stinissen P, Hellings N. Pathogenic features of CD41CD28- T cells in immune disorders. Trends Mol Med 2012;18:446-453.
15. Koetz K, Bryl E, Spickschen K, O'Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 2000;97:9203-9208.
16. Schönland SO, Lopez C, Widmann T, Zimmer J, Bryl E, Goronzy JJ, Weyand CM. Premature telomeric loss in rheumatoid arthritis is genetically determined and involves both myeloid and lymphoid cell lineages. Proc Natl Acad Sci USA 2003;100:13471-13476.
17. Hohensinner PJ, Goronzy JJ, Weyand CM. Telomere dysfunction, autoimmunity and aging. Aging Dis 2011;2:524-537.
18. Andrews NP, Fujii H, Goronzy JJ, Weyand CM. Telomeres and immunological diseases of aging. Gerontology 2010;56:390-403.
19. Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 2008;58:990-1000.
20. Weyand CM, Fujii H, Shao L, Goronzy JJ. Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 2009;5:583-588.
21. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 2000;101:2883-2888.
22. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, Weyand CM. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999;100:2135-2139.
23. Liuzzo G, Vallejo AN, Kopecky SL, Frye RL, Holmes DR, Goronzy JJ, Weyand CM. Molecular fingerprint of interferon-g signaling in unstable angina. Circulation 2001;103:1509-1514.
24. Nakajima T, Schulte S, Warrington KJ, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. T-cell-mediated lysis of endothelial cells in acute coronary syndromes. Circulation 2002;105:570-575.
25. Zhang X, Niessner A, Nakajima T, Ma-Krupa W, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque. Circ Res 2006;98: 524-531.
26. Nakajima T, Goek O, Zhang X, Kopecky SL, Frye RL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 2003;93: 106-113.
27. Dehbi AZ, Radstake TR, Broen JC. Accelerated telomere shortening in rheumatic diseases: cause or consequence? Expert Rev Clin Immunol 2013;9:1193-1204.
28. Czesnikiewicz-Guzik M, Lee WW, Cui D, Hiruma Y, Lamar DL, Yang ZZ, Ouslander JG, Weyand CM, Goronzy JJ. T cell subset-specific susceptibility to aging. Clin Immunol 2008;127:107-118.
29. Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, Currier NL, Nikolich-Žugich D, Kaye J, Nikolich-Žugich J. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol 2014;192: 2143-2155.
30. Son NH, Murray S, Yanovski J, Hodes RJ, Weng N. Lineage-specific telomere shortening and unaltered capacity for telomerase expression in human T and B lymphocytes with age. J Immunol 2000;165:1191-1196.
31. Hodes RJ, Hathcock KS, Weng NP. Telomeres in T and B cells. Nat Rev Immunol 2002;2:699-706.
32. Fujii H, Shao L, Colmegna I, Goronzy JJ, Weyand CM. Telomerase insufficiency in rheumatoid arthritis. Proc Natl Acad Sci USA 2009; 106:4360-4365.
33. Feuerhahn S, Chen LY, Luke B, Porro A. No DDRama at chromosome ends: TRF2 takes centre stage. Trends Biochem Sci 2015;40: 275-285.
34. Shao L, Fujii H, Colmegna I, Oishi H, Goronzy JJ, Weyand CM. Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med 2009;206:1435-1449.
35. Maas K, Westfall M, Pietenpol J, Olsen NJ, Aune T. Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation-induced apoptosis. Arthritis Rheum 2005;52:1047-1057.
36. Shao L, Goronzy JJ, Weyand CM. DNA-dependent protein kinase catalytic subunit mediates T-cell loss in rheumatoid arthritis. EMBO Mol Med 2010;2:415-427.
37. Espejel S, Martín M, Klatt P, Martín-Caballero J, Flores JM, Blasco MA. Shorter telomeres, accelerated ageing and increased lymphoma in DNA-PKcs-deficient mice. EMBO Rep 2004;5:503-509.
38. Kyriakis JM, Avruch J. Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update. Physiol Rev 2012;92:689-737.
39. Palmer CS, Ostrowski M, Balderson B, Christian N, Crowe SM. Glucose metabolism regulates T cell activation, differentiation, and functions. Front Immunol 2015;6:1.
40. Yang Z, Matteson EL, Goronzy JJ, Weyand CM. T-cell metabolism in autoimmune disease. Arthritis Res Ther 2015;17:29.
41. Yang Z, Shen Y, Oishi H, Matteson EL, Tian L, Goronzy JJ, Weyand CM. Restoring oxidant signaling suppresses proarthritogenic T cell effector functions in rheumatoid arthritis. Sci Transl Med 2016;8: 331ra38.
42. Yang Z, Fujii H, Mohan SV, Goronzy JJ, Weyand CM. Phosphofructokinase deficiency impairs ATP generation, autophagy, and redox balance in rheumatoid arthritis T cells. J Exp Med 2013;210: 2119-2134.
43. Collins RH, Lack L, Killenberg PG. Rat hepatic bile acid sulfotransferase: enzyme response to androgens and estrogens. Am J Physiol 1987;252:G276-G280.
44. Yang Z, Goronzy JJ, Weyand CM. Autophagy in autoimmune disease. J Mol Med (Berl) 2015;93:707-717.
45. Fang F, Yu M, Cavanagh MM, Hutter Saunders J, Qi Q, Ye Z, Le Saux S, Sultan W, Turgano E, Dekker CL, et al. Expression of CD39 on activated T cells impairs their survival in older individuals. Cell Reports 2016;14:1218-1231.
46. Selman C, Tullet JM, Wieser D, Irvine E, Lingard SJ, Choudhury AI, Claret M, Al-Qassab H, Carmignac D, Ramadani F, et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009;326:140-144.
47. Yu M, Li G, Lee WW, Yuan M, Cui D, Weyand CM, Goronzy JJ. Signal inhibition by the dual-specific phosphatase 4 impairs T cell- dependent B-cell responses with age. Proc Natl Acad Sci USA 2012;109:E879-E888.
48. Li G, Yu M, Lee WW, Tsang M, Krishnan E, Weyand CM, Goronzy JJ. Decline in miR-181a expression with age impairs T cell receptor sensitivity by increasing DUSP6 activity. Nat Med 2012;18:1518-1524.
49. Whiting CC, Siebert J, Newman AM, Du HW, Alizadeh AA, Goronzy J, Weyand CM, Krishnan E, Fathman CG, Maecker HT. Large-scale and comprehensive immune profiling and functional analysis of normal human aging. PLoS One 2015;10:e0133627.
50. Jagger A, Shimojima Y, Goronzy JJ, Weyand CM. Regulatory T cells and the immune aging process: a mini-review. Gerontology 2014;60:130-137.
51. Suzuki M, Jagger AL, Konya C, Shimojima Y, Pryshchep S, Goronzy JJ, Weyand CM. CD81CD45RA1CCR71FOXP31 T cells with immunosuppressive properties: a novel subset of inducible human regulatory T cells. J Immunol 2012;189:2118-2130.
52. Wen Z, Shimojima Y, Shirai T, Li Y, Ju J, Yang Z, Tian L, Goronzy JJ, Weyand CM. NADPH oxidase deficiency underlies dysfunction of aged CD81 Tregs. J Clin Invest 2016;126:1953-1967.
53. Olshansky SJ. Articulating the case for the longevity dividend. Cold Spring Harb Perspect Med 2016;6:a025940.
54. Goronzy JJ, Qi Q, Olshen RA, Weyand CM. High-throughput sequencing insights into T-cell receptor repertoire diversity in aging. Genome Med 2015;7:117.
55. Qi Q, Liu Y, Cheng Y, Glanville J, Zhang D, Lee JY, Olshen RA, Weyand CM, Boyd SD, Goronzy JJ. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci USA 2014;111: 13139-13144.
56. Qi Q, Zhang DW, Weyand CM, Goronzy JJ. Mechanisms shaping the naive T cell repertoire in the elderly: thymic involution or peripheral homeostatic proliferation? Exp Gerontol 2014;54:71-74.
57. Cavanagh MM, Weyand CM, Goronzy JJ. Chronic inflammation and aging: DNA damage tips the balance. Curr Opin Immunol 2012;24: 488-493.
58. Goronzy JJ, Li G, Yu M, Weyand CM. Signaling pathways in aged T cells: a reflection of T cell differentiation, cell senescence and host environment. Semin Immunol 2012;24:365-372.
59. Hohensinner PJ, Goronzy JJ, Weyand CM. Targets of immune regeneration in rheumatoid arthritis. Mayo Clin Proc 2014;89: 563-575.